Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 70518-3862

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 70518-3862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of a medication called Buprenorphine / Naloxone. It is a sublingual tablet with a dosage of 2mg Buprenorphine and 0.5mg Naloxone. The package contains 30 tablets. The medication is intended for prescription use only and should be kept out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted between 15-30°C (54-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA, with contact information as 724.465.8762.*

FDA Label Image

Buprenorphine-chem-structure.jpg (Image 02)

FDA Label Image

Bupr-naloxone-ifu-mouth-image (Image 03)

FDA Label Image

Naloxone-chem-structure.jpg (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.